Potential biological targets ofBacillus anthracisin anti-infective approaches against the threat of bioterrorism
- 1 August 2007
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Anti-infective Therapy
- Vol. 5 (4) , 665-684
Abstract
The terrorist attacks of 2001 involving anthrax underscore the imperative that safe and effective medical countermeasures should be readily available. Vaccination appears to be the most effective form of mass protection against a biological attack, but the current vaccines have drawbacks that justify the enormous amount of effort currently being put into developing more effective vaccines and other treatment modalities. After providing a comprehensive overview of the organism Bacillus anthracis as a biological weapon and its pathogenicity, this review briefly summarizes the current knowledge vital to the management of anthrax disease. This knowledge has been acquired since 2001 as a result of the progress on anthrax research and focuses on the possible development of improved human anti-infective strategies targeting B. anthracis spore components, as well as strategies based on host-pathogen interactions.Keywords
This publication has 197 references indexed in Scilit:
- Multicomponent anthrax toxin display and delivery using bacteriophage T4Vaccine, 2007
- Synthetic small molecule furin inhibitors derived from 2,5-dideoxystreptamineProceedings of the National Academy of Sciences, 2006
- Anthrax pathogen evades the mammalian immune system through stealth siderophore productionProceedings of the National Academy of Sciences, 2006
- Retrocyclins Kill Bacilli and Germinating Spores of Bacillus anthracis and Inactivate Anthrax Lethal ToxinJournal of Biological Chemistry, 2006
- Polyvalent inhibitors of anthrax toxin that target host receptorsProceedings of the National Academy of Sciences, 2006
- Rabies virus glycoprotein as a carrier for anthrax protective antigenVirology, 2006
- Short-course postexposure antibiotic prophylaxis combined with vaccination protects against experimental inhalational anthraxProceedings of the National Academy of Sciences, 2006
- Cross-inhibition between furin and lethal factor inhibitorsBiochemical and Biophysical Research Communications, 2004
- Immune system paralysis by anthrax lethal toxin: the roles of innate and adaptive immunityThe Lancet Infectious Diseases, 2004
- The genome sequence of Bacillus anthracis Ames and comparison to closely related bacteriaNature, 2003